Insider Buying: Accelerate Diagnostics Major Shareholder Buys 84,081 Shares of Stock (AXDX)
Accelerate Diagnostics (NASDAQ:AXDX) major shareholder Larry Feinberg acquired 84,081 shares of the stock on the open market in a transaction dated Tuesday, December 31st. The shares were purchased at an average price of $12.29 per share, for a total transaction of $1,033,355.49. Following the purchase, the insider now directly owns 20,000 shares of the company’s stock, valued at approximately $245,800. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Large shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.
Shares of Accelerate Diagnostics (NASDAQ:AXDX) traded up 2.66% during mid-day trading on Friday, hitting $11.59. 115,702 shares of the company’s stock traded hands. Accelerate Diagnostics has a 1-year low of $4.00 and a 1-year high of $16.45. The stock has a 50-day moving average of $13.18 and a 200-day moving average of $10.93. The company’s market cap is $480.6 million.
Accelerate Diagnostics, Inc, formerly Accelr8 Technology Corporation, is focused on developing and commercializing instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.